| GO ID | GO:0008201 |
| Ontology | MF |
| GO Term | heparin binding |
| Definition | Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
9510 | Q9UHI8 | chr21: 26,835,747-26,845,409 |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif 15 |
170689 | Q8TE58 | chr11: 130,448,974-130,476,641 |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
11096 | Q9UNA0 | chr21: 26,917,912-26,966,513 |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif 8 |
11095 | Q9UP79 | chr11: 130,404,925-130,428,993 |
ADGRG1 | adhesion G protein-coupled receptor G1 |
9289 | Q9Y653 | chr16: 57,610,652-57,665,580 |
ANG | angiogenin, ribonuclease, RNase A family, 5 |
283 | P03950 | chr14: 20,684,177-20,698,971 |
ANOS1 | anosmin 1 |
3730 | P23352 | chrX: 8,528,874-8,732,186 |
APLP2 | amyloid beta (A4) precursor-like protein 2 |
334 | Q06481 | chr11: 130,069,837-130,144,811 |
APOA5 | apolipoprotein A-V |
116519 | Q6Q788 | chr11: 116,789,367-116,792,420 |
APOB | apolipoprotein B |
338 | P04114 | chr2: 21,001,429-21,044,073 |
APOE | apolipoprotein E |
348 | P02649 | chr19: 44,905,754-44,909,393 |
APOH | apolipoprotein H |
350 | P02749 | chr17: 66,212,033-66,256,525 |
APP | amyloid beta (A4) precursor protein |
351 | P05067 | chr21: 25,880,550-26,171,128 |
BMP4 | bone morphogenetic protein 4 |
652 | P12644 | chr14: 53,949,736-53,958,761 |
CCDC80 | coiled-coil domain containing 80 |
151887 | Q76M96 | chr3: 112,596,794-112,649,530 |
CCL2 | chemokine (C-C motif) ligand 2 |
6347 | P13500 | chr17: 34,255,218-34,257,203 |
CCL8 | chemokine (C-C motif) ligand 8 |
6355 | P80075 | chr17: 34,319,036-34,321,402 |
CFH | complement factor H |
3075 | P08603 | chr1: 196,651,878-196,747,504 |
CLEC3B | C-type lectin domain family 3 member B |
7123 | P05452 | chr3: 45,001,548-45,036,071 |
COL13A1 | collagen, type XIII, alpha 1 |
1305 | Q5TAT6 | chr10: 69,801,931-69,964,275 |
COL5A1 | collagen, type V, alpha 1 |
1289 | P20908 | chr9: 134,641,774-134,844,843 |
COL5A3 | collagen, type V, alpha 3 |
50509 | P25940 | chr19: 9,959,561-10,010,471 |
COMP | cartilage oligomeric matrix protein |
1311 | P49747 | chr19: 18,782,773-18,791,314 |
CRISPLD2 | cysteine-rich secretory protein LCCL domain containing 2 |
83716 | Q9H0B8 | chr16: 84,819,984-84,920,768 |
CTGF | connective tissue growth factor |
1490 | P29279 | chr6: 131,948,176-131,951,373 |
CXCL6 | chemokine (C-X-C motif) ligand 6 |
6372 | P80162 | chr4: 73,836,497-73,849,064 |
CYR61 | cysteine-rich, angiogenic inducer, 61 |
3491 | O00622 | chr1: 85,580,761-85,583,962 |
ECM2 | extracellular matrix protein 2, female organ and adipocyte specific |
1842 | O94769 | chr9: 92,493,554-92,536,655 |
EPYC | epiphycan |
1833 | Q99645 | chr12: 90,963,679-91,005,026 |
FBN1 | fibrillin 1 |
2200 | P35555 | chr15: 48,408,306-48,645,849 |
FGF2 | fibroblast growth factor 2 (basic) |
2247 | P09038 | chr4: 122,826,708-122,898,236 |
FGF7 | fibroblast growth factor 7 |
2252 | P21781 | chr15: 49,423,096-49,488,775 |
FGF9 | fibroblast growth factor 9 |
2254 | P31371 | chr13: 21,671,383-21,704,498 |
FGFR1 | fibroblast growth factor receptor 1 |
2260 | P11362 | chr8: 38,411,138-38,468,834 |
FGFR2 | fibroblast growth factor receptor 2 |
2263 | P21802 | chr10: 121,478,334-121,598,458 |
FMOD | fibromodulin |
2331 | Q06828 | chr1: 203,340,628-203,351,489 |
FN1 | fibronectin 1 |
2335 | P02751 | chr2: 215,360,440-215,436,172 |
FSTL1 | follistatin like 1 |
11167 | Q12841 | chr3: 120,392,293-120,451,253 |
GPNMB | glycoprotein (transmembrane) nmb |
10457 | Q14956 | chr7: 23,235,967-23,275,108 |
GREM2 | gremlin 2, DAN family BMP antagonist |
64388 | Q9H772 | chr1: 240,489,573-240,612,149 |
HBEGF | heparin-binding EGF-like growth factor |
1839 | Q99075 | chr5: 140,332,843-140,346,631 |
HDGF | hepatoma-derived growth factor |
3068 | P51858 | chr1: 156,742,107-156,766,925 |
HSD17B12 | hydroxysteroid (17-beta) dehydrogenase 12 |
51144 | Q53GQ0 | chr11: 43,680,558-43,856,617 |
KNG1 | kininogen 1 |
3827 | P01042 | chr3: 186,717,276-186,743,954 |
LIPG | lipase, endothelial |
9388 | Q9Y5X9 | chr18: 49,560,699-49,599,182 |
LIPH | lipase, member H |
200879 | Q8WWY8 | chr3: 185,506,262-185,552,613 |
LPL | lipoprotein lipase |
4023 | P06858 | chr8: 19,901,717-19,967,258 |
LRPAP1 | LDL receptor related protein associated protein 1 |
4043 | P30533 | chr4: 3,506,376-3,532,559 |
LXN | latexin |
56925 | Q9BS40 | chr3: 158,645,822-158,672,693 |
MDK | midkine (neurite growth-promoting factor 2) |
4192 | P21741 | chr11: 46,380,756-46,383,837 |
MPO | myeloperoxidase |
4353 | P05164 | chr17: 58,269,856-58,280,935 |
MSTN | myostatin |
2660 | O14793 | chr2: 190,055,697-190,062,729 |
NAV2 | neuron navigator 2 |
89797 | Q8IVL1 | chr11: 19,350,724-20,121,598 |
NDNF | neuron-derived neurotrophic factor |
79625 | Q8TB73 | chr4: 121,035,613-121,073,021 |
NRP1 | neuropilin 1 |
8829 | O14786 | chr10: 33,177,492-33,336,262 |
NRP2 | neuropilin 2 |
8828 | O60462 | chr2: 205,681,990-205,798,133 |
OGN | osteoglycin |
4969 | P20774 | chr9: 92,383,967-92,404,696 |
PCOLCE | procollagen C-endopeptidase enhancer |
5118 | Q15113 | chr7: 100,602,177-100,608,175 |
PCOLCE2 | procollagen C-endopeptidase enhancer 2 |
26577 | Q9UKZ9 | chr3: 142,815,922-142,889,203 |
PCSK6 | proprotein convertase subtilisin/kexin type 6 |
5046 | P29122 | chr15: 101,297,142-101,525,202 |
PDCD5 | programmed cell death 5 |
9141 | O14737 | chr19: 32,581,068-32,587,452 |
PF4 | platelet factor 4 |
5196 | P02776 | chr4: 73,981,077-73,982,124 |
PGF | placental growth factor |
5228 | P49763 | chr14: 74,941,834-74,955,784 |
PLA2G5 | phospholipase A2 group V |
5322 | P39877 | chr1: 20,028,179-20,091,190 |
POSTN | periostin, osteoblast specific factor |
10631 | Q15063 | chr13: 37,562,583-37,598,844 |
PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
5553 | P13727 | chr11: 57,386,794-57,390,657 |
PTCH1 | patched 1 |
5727 | Q13635 | chr9: 95,442,980-95,517,057 |
PTPRF | protein tyrosine phosphatase, receptor type, F |
5792 | P10586 | chr1: 43,525,187-43,623,666 |
RPL22 | ribosomal protein L22 |
6146 | P35268 | chr1: 6,181,269-6,209,389 |
RPL29 | ribosomal protein L29 |
6159 | P47914 | chr3: 51,993,600-51,995,942 |
RSPO3 | R-spondin 3 |
84870 | Q9BXY4 | chr6: 127,118,604-127,197,765 |
SAA1 | serum amyloid A1 |
6288 | P0DJI8 | chr11: 18,266,174-18,269,977 |
SELL | selectin L |
6402 | P14151 | chr1: 169,690,667-169,711,698 |
SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
5104 | P05154 | chr14: 94,561,442-94,593,120 |
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 |
462 | P01008 | chr1: 173,903,804-173,917,378 |
SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
5270 | P07093 | chr2: 223,975,112-224,039,319 |
SFRP1 | secreted frizzled-related protein 1 |
6422 | Q8N474 | chr8: 41,261,958-41,309,497 |
SLIT2 | slit guidance ligand 2 |
9353 | O94813 | chr4: 20,253,260-20,620,561 |
SMOC2 | SPARC related modular calcium binding 2 |
64094 | Q9H3U7 | chr6: 168,441,151-168,673,445 |
SOD3 | superoxide dismutase 3, extracellular |
6649 | P08294 | chr4: 24,789,912-24,800,842 |
SOST | sclerostin |
50964 | Q9BQB4 | chr17: 43,753,731-43,758,788 |
TGFBR3 | transforming growth factor beta receptor III |
7049 | Q03167 | chr1: 91,680,343-91,906,335 |
THBS1 | thrombospondin 1 |
7057 | P07996 | chr15: 39,581,079-39,599,466 |
THBS4 | thrombospondin 4 |
7060 | P35443 | chr5: 79,991,311-80,083,287 |
TNXB | tenascin XB |
7148 | P22105 | chr6: 32,041,154-32,115,334 |
VEGFA | vascular endothelial growth factor A |
7422 | P15692 | chr6: 43,770,184-43,786,487 |
VEGFB | vascular endothelial growth factor B |
7423 | P49765 | chr11: 64,234,538-64,238,793 |
VTN | vitronectin |
7448 | P04004 | chr17: 28,367,276-28,373,091 |
WISP1 | WNT1 inducible signaling pathway protein 1 |
8840 | O95388 | chr8: 133,191,039-133,230,344 |
WISP2 | WNT1 inducible signaling pathway protein 2 |
8839 | O76076 | chr20: 44,714,844-44,728,509 |
ZNF207 | zinc finger protein 207 |
7756 | O43670 | chr17: 32,350,117-32,381,886 |